Qualifying Therapeutic Discovery Project Credit for the State of Connecticut
The listings below represent the applicants that are eligible for a Qualifying Therapeutic Discovery Program Credit.
The project descriptions below were extracted from the applicant certification forms as submitted. The list provides only the applicant name and amount of the credit for each project for which the disclosure of additional information was not authorized.
|Applicant Name||Project Name||Eligible Credit Amount 2009||Eligible Credit Amount 2010|
|L2 Diagnostics LLC||Antimicrobials Targeting the D-Alanine Pathway||$ 45,717.50||$ 198,761.75|
|L2 Diagnostics LLC||Novel vaccines and therapeutics for the prevention and treatment of flavivirus infections||$ 244,479.25|
|L2 Diagnostics, LLC||EGFR Peptides as Vaccine in Anti-Tumor Immunity||$ 38,051.00||$ 86,187.50|
|L2 Diagnostics, LLC||Glioma Cancer Therapeutics||$ 27,045.50||$ 26,282.50|
|L2 Diagnostics, LLC||Novel diagnostics for tick-borne diseases||$ 95,016.50||$ 93,019.00|
|L2 Diagnostics, LLC||Novel Therapeutics Targeting MIF for Inhibition of Inflammation||$ 20,567.00||$ 72,890.00|
|L2 Diagnostics, LLC||Modified HER-2 Tumor Antigens for Vaccination in Cancer||$ 69,709.00||$ 104,752.00|